New gene test offers personalized treatment for inherited neuromuscular disorder
Friday, February 11, 2011 - 11:01
in Health & Medicine
The gene, GFPT1, has been identified by researchers at Newcastle University working with international colleagues, as crucial in causing a variation of Congenital Myasthenic Syndrome (CMS).